TruStem Cell Therapy™ for COPD
Frequent coughing (with and without sputum)
Tightness in chest
Reliance on supplementary oxygen
What is COPD?
Chronic obstructive pulmonary disease (COPD) is a progressive, degenerative lung disease resulting from a long-term inflammatory response to inhaled irritants. As the inflammatory process continues, the small airways narrow, inhibiting airflow; and healthy lung tissue is broken down, preventing appropriate absorption of oxygen. Due to these disease processes, the ability to breathe becomes increasingly difficult. Eventually, even simple tasks and short bursts of activity can heavily strain an individual’s stamina. The result is a substantially reduced quality of life for an individual with COPD.
There are 2 main types of COPD:
is a common type of COPD in which the air sacs of the lungs become damaged, causing them to enlarge and burst. Damage in this area makes it difficult for people with emphysema to expel air from their lungs.
causes inflammation and irritation of the airways, the tubes in your lungs where air passes through. When the air tubes are inflamed and irritated, thick mucus begins to form in them. Over time, this mucus plugs up airways and makes breathing difficult.
Although there is no cure for the disease, many patients can experience a significant reduction in the severity of their symptoms through stem cell therapy for COPD. With a stem cell transplant for COPD to targeted areas in the lungs and airway, the progression of the disease can be slowed and the patient’s quality of life can be improved by the lessening of the disease’s symptoms and complications. By focusing treatment on the specific areas of the respiratory system that are affected by the disease, stem cell therapy has the potential to make life easier for patients who have COPD. TruStem Cell Therapy has the potential to relieve multiple complications related to COPD, such as reduced stamina, decreased mobility, shortness of breath and respiratory infections.
What causes COPD?
About 85 to 90 percent of all COPD cases are caused by cigarette smoking. When a cigarette burns, it creates more than 7,000 chemicals, many of which are harmful. The toxins in cigarette smoke weaken your lungs’ defense against infections, narrow air passages, cause swelling in air tubes and destroy air sacs—all contributing factors for COPD.
What you breathe every day at work, home and outside can play a role in developing COPD. Long-term exposure to air pollution, secondhand smoke and dust, fumes and chemicals (which are often work-related) can cause COPD.
A small number of people have a rare form of COPD called alpha-1 deficiency-related emphysema. This form of COPD is caused by a genetic (inherited) condition that affects the body’s ability to produce a protein (Alpha-1) that protects the lungs.
What type of stem cells are used and why?
TruStem Cell Therapy provides access to treatment that utilizes a patient’s stem cells isolated from their own bone marrow. There are multiple inherent benefits afforded by the utilization of bone marrow derived stem cells as Bone marrow (BM) and bone marrow components function in various diverse, innate therapeutic capacities.
Hematopoietic stem cells (HSCs), found within BM, are the body’s source of most cells found in the peripheral or circulating blood. These include red blood cells and white blood cells (such as monocytes). In addition to HSCs, mesenchymal stem cells (MSCs) are also contained within BM. Evidence suggests MSCs can enter the circulating blood during injury and have been shown to readily home to areas of injury or inflammation. Once at these damaged tissue sites, MSCs can exert both protective cellular and immunomodulatory effects including their ability to differentiate into a broad variety of cells types (neurons, bone, cartilage, muscle, tendon, etc.), they are present at comparatively much higher levels than other stem cell types, possess unique immune-modulating properties, and they do not endanger a patient’s health the way other stem cells might.
What steps are involved in receiving treatment through TruStem Cell Therapy™?
How are stem cells administered back into COPD patients through TruStem Cell Therapy?
COPD patients who receive stem cell therapy through us can receive multiple systemic and targeted administration methods:
Systemic IV infusion of their stem cells to fully saturate the entire body.
Stem cells are delivered via a nebulizer for distribution throughout and deep into the lungs as the patients breathe in the stem cells.
What is unique about receiving stem cell therapy through TruStem Cell Therapy™ for COPD?
Our focus is safety, efficacy, and patient-centric care when providing access to superior stem cell therapy.
We utilize only board-certified surgeons, physicians and accredited clinicians to provide care for patients.
Laboratory protocols are developed and refined by our PhD Neuroscientist.
A clinical team with expertise in practicing cellular based medicine.
Accredited Surgical Centers for enhanced procedural and patient safety
Skilled Patient Advocates who are trained to provide truthful, realistic expectations resulting from stem cell therapy. We do not make outlandish promises of cures or inaccurate claims related to improvement rates.
Can this treatment cure COPD?
It is important for patients and caregivers to understand that current therapies, including stem cell treatment, do not provide a cure for COPD. However, TruStem Cell Therapy does have the potential to improve a patient’s quality of life by reducing symptoms and complications related to COPD as well as slowing its progression.